SEC Form DFiling only, no announcement found
Swep Bio, based in Scarsdale, NY, reported $2,499,989 sold in a private offering of equity, with the first sale on October 28, 2026, in a Form D filed with the SEC on October 29, 2026. The filing says 1 investor has already invested. The offering authorizes up to $4,999,976.
Legal name on the filing: Swep Bio, Inc..
| Amount sold | $2,499,989Basis: Form D total amount sold, as of the filing of October 29, 2026. Not the announced round size. |
|---|---|
| Total offering | $4,999,976The most the company may sell under this offering. Not money raised. |
| Remaining to be sold | $2,499,987 |
| Securities offered | Equity |
| Exemption claimed | Rule 506(b) |
| Date of first sale | October 28, 2026 |
| Investors already invested | 1 |
| Non-accredited investors | None |
| Minimum investment accepted | $0 |
| Part of a merger or acquisition | No |
| Industry group | Biotechnology |
| Principal place of business | Scarsdale, NY |
| Jurisdiction of incorporation | DELAWARE |
| Entity type | Corporation |
| Year of incorporation | 2026 |
| Revenue range | Decline to Disclose |
| SEC CIK | 2159106 |
Round name, valuation, lead investor and participants are not on a Form D, so they are not shown. They appear here only when a press or company announcement is matched to this deal.
| Name, as filed | Relationship | VC Beast profile |
|---|---|---|
| Goran Mikael Dolsten | Executive Officer, Director | None linked |
| Karl Erik Emanuel Berglund | Executive Officer, Director | None linked |
| Lovisa Backemar | Director | None linked |
Form D lists the company's executive officers, directors and promoters. A director is often an investor's board representative, but the filing does not say who invested.
| Filed | Form | Amount sold | Total offering |
|---|---|---|---|
| Oct 29, 2026 | D (original) | $2,499,989 | $4,999,976 |
The latest filing states the current amount sold; an amendment replaces the figure before it.
Filing only, no announcement found. The only source for this deal is the company's own SEC filing, made under penalty of law. When a press or company announcement is matched to it, it is cited here with the round name it gives.
Amount sold is the filing's total amount sold; total offering is its authorized maximum. This page was built from filings received through November 13, 2026. Report an error on the corrections page.
Cite this deal
VC Beast, "Swep Bio: SEC Form D deal record", https://vcbeast.com/deals/swep-bio-form-d-2026-10-28. Source: SEC EDGAR, accession 0002159106-26-000001.